Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2022 Feb 6;48(6):101129. doi: 10.1016/j.cpcardiol.2022.101129

Aortic dissection and Covid-19; a comprehensive systematic review

Alireza Ramandi a,b,, Mohammad Ali Akbarzadeh c,, Isa Khaheshi d,, Mohammad Reza Khalilian e
PMCID: PMC8817949  PMID: 35139402

Abstract

Coronavirus disease 19 (Covid-19) has been declared as a pandemic disease since March 2020; causing wide array of signs and symptoms, many of which result in increased mortality rates worldwide. Although it was initially known as an acute respiratory disease, Covid-19 is accompanied with several extrapulmonary manifestations, of which the cardiovascular ones are of major importance. Among other cardiovascular complications of Covid-19, aortic dissection has been a significant yet underrated problem. The pathophysiology of aortic dissection consists of various inflammatory pathways, that could be influenced by Covid-19 infection. We herein have reviewed articles inclusive of aortic dissection concurrent with Covid-19 infection in a systematic manner, along with the probable similarities in pathophysiology of aortic dissection with Covid-19 infection.

Introduction

Since 11th March 2020, the outbreak of severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) has been declared as a pandemic disease, causing numerous morbidities and mortalities worldwide.1 , 2 Although Coronavirus disease 19 (Covid-19) had been Initially known as an acute respiratory distress syndrome, more recently it appeared to affect various organs and organ systems, including cardiovascular, gastrointestinal, renal, coagulation, and skin disorders; Most of which related to the hyper-inflammatory state in Covid-19.3 , 4 Multiple findings imply that the inflammatory state in Covid-19 patients is similar to strong inflammatory syndrome; both of which showing abnormal platelet count, increase in D-dimer, increase in Von Willebrand Factor (VWF), endothelialitis, and pro-inflammatory cytokines activation.3

The Covid-19 is known to cause increased risk of several cardiovascular complications; including acute myocardial injury, arrhythmias, cardiogenic shock, acute coronary syndrome, and venous thromboembolism.4 Among the cardiac complications, aortic dissection is an important yet underrated problem in Covid-19 patients. Even though few articles indicate that the rate of aortic dissection has been increased during the course of pandemic, no comprehensive studies have been conducted about the molecular basis and coincidence rate of Covid-19 and aortic dissection.5

We herein report a comprehensive systematic review of literature to cognize the patients with aortic dissection and concurrent or previous Covid-19. We have also discussed the similarities between the pathologic pathway of Covid-19 and aortic dissection.

Pathophysiology

Aortic dissection is the blood passage into the aortic media as a result of the rupture in intimal layer of the aortic wall.6 Consequently, separation of the intimal layer from the outer layers occurs, and hence a false lumen appears in juxtaposition with the main aortic lumen. The ascending aorta is reported to be the most common site of aortic dissection, as 65% of the dissections originate in this region.7

Numerous major risk factors contribute to increased risk of aortic dissection, including hypertension and smoking, and genetic factors such as Marfan Syndrome (MFS) and Ehlers Danlos.6 Vasculitis is also a notable factor that increases the risk of aortic dissection, as in Takayasu arteritis, Behcet's disease, and syphilis infection.7 Interestingly, Numerous articles mentioned Covid-19 infection as a strong inflammatory syndrome.3 , 8 Moreover, there are multiple cases of Covid-19 patients with hyper-inflammation who have had cardiac manifestations such as coronary microvascular dysfunction and peripheral artery thrombosis.9 , 10

There are several similarities between molecular pathways and markers of aortic dissection and Covid-19. For instance, the level of Von Willebrand Factor (VWF) Increases in Covid-19 patients, which is indicative of extensive endothelial cell activation.3 Multiple molecular factors are known to be correlated in MFS and aortic dissection that are also elevated in Covid-19 patients. (Fig 1 ) The major factors include Transforming growth factor beta (TGF-β), total plasma homocysteine Y (tHCy), and Matrix metalloproteinases (MMPs).11, 12, 13

FIG 1.

FIG 1

The similarities in molecular pathologic pathway of Covid-19 hyper-inflammatory state, aortic dissection, and Marfan syndrome. TGF- β, tHCy, and MMP3 are the major mutual pathways in Aortic dissection, Marfan syndrome, and Covid-19 infection. There are not enough data in literature approving the role of FBN1 and LOX gene in Covid-19 inflammation. FBN1, Fibrillin 1 gene; LOX, Lysyl oxidase; MMP3, matrix metalloproteinase-3; TGF- β, Transforming growth factor beta; tHCy, total plasma homocysteine Y.

Several reports illustrated that excessive activation of TGF-β in MFS patients is correlated with aortic root dilation and predisposition to aortic dissection.12 Ghazavi et al. indicated that in a study of 63 Covid-19 patients and their matched controls, the level of TGF-β increased in Covid-19 patients. Furthermore, TGF-β in this study was significantly higher in patients with severe form of Covid-19 compared to the patients with mild form. With these findings, one may assume that the Covid-19 can possibly increase the probability of aortic root dilation and henceforth aortic dissection. It is worthy to mention that in MFS patients, treatment with β-blockers decreases the TGF-β levels.

According to the literature, the tHCy is described as a marker of the level of aortic atherosclerosis. Moreover, in a study of one hundred and seven patients, Giusti et al. concluded that higher levels of tHCy in MFS patients is correlated with the incidence rate of aortic dissection and other cardiovascular complications.12 , 14 In case of Covid-19, it has been shown that tHCy can be used as a predictive value for the severity of the disease, as the higher levels of tHCy corresponds to more severe pneumonia in imaging evaluations.

One of the major similarities between MFS patients with aortic dissection and Covid-19 patients, is the imbalance between MMP and Tissue inhibitor of metalloproteinase (TIMP).

Prior studies have demonstrated that macrophage infiltration in the media layer of aorta may result in excessive production of MMPs, specifically MMP-1, MMP-9 and MMP-12. As a result, collagen and elastin degeneration leads to aortic aneurysms and aortic dissections.2

One of the molecular characteristics of MFS is known to be increased expression of MMPs, that ensues an imbalance between MMP and TIMP levels.12 Speaking of MMPs in Covid-19, several studies have reported an increase in MMPs expression. Shi et al. studied sixty-two cases of Covid-19 and their matched controls, and reported a significant rise in serum MMP3 levels in Covid-19. As mentioned in the article, MMP3 activates other MMPs, including MMP9.15 Additionally, Neutrophils response to viral infection is followed by MMP9 release from neutrophil granules. This process was previously known th contribute to lung damage in Covid-19 patients.16

Considering macrophage molecular pathway activation in Covid-19 patients, there are several other markers that are increased; including Ferritin, IL-15, IL-1β, IL-18. There has been a significant difference in Ferritin and IL-15 levels in Covid-19 patients with critically ill situations compared to other patients and healthy individuals.17 These findings imply that there are several major pathway similarities between aortic dissection and the inflammation caused by Covid-19 infection.

For the LOX and FBN1 gene pathways, as two other factors that predispose MFS patients to aortic dissection, there is not enough evidence that Covid-19 has a similar pathway and hence is correlated. However, this idea may lead to further investigations in future publications.

Method

A comprehensive search was conducted on PubMed, Embase, Scopus, and Google scholar for the articles that have been published until January 2, 2022. Proper Boolean operators have been used for the subject headings “Covid-19” and “dissection” and any synonyms observed in literature. Multiple combinations of words have been used to ensure a comprehensive search. Indexing methods (e.g., Mesh terms, Emtree, etc.) were also utilized if available. The search was conducted by one reviewer and crosschecked by another. From the initial articles in the primary search, the duplicates and unrelated articles were excluded. After primary screening, suitable quality appraisal tool was utilized to assess the article before data extraction.18 , 19 The exclusion criteria were 1) article written in languages other than English, 2) reviews and commentaries without any patients studied, 3) lack of demographic, clinical, imaging or laboratory evidences of Covid-19 infection, 4) insufficient details of the type of acute aortic syndrome (i.e., articles which did not differentiate dissection from aneurysm or other manifestations of acute aortic syndrome in the patients discussed). Due to unavailability of reverse transcription polymerase chain reaction test (RT-PCR) early in the course of the pandemic, we did not exclude patients who were diagnosed with Covid-19 based on clinical or imaging methods. Statistical analysis was conducted by using SPSS software (SPSS Inc, Chicago, Illinois, USA).

Results

Initially, 246 articles were obtained from the primary search. After comprehensive analysis of the articles according to Figure 2 , 19 articles met the criteria for data extraction and qualitative synthesis (Table 1 ). Due to lack of eligible study types other than case reports, quantitative synthesis was considered inapplicable.

FIG 2.

FIG 2

Flow diagram for the systematic review according to PRISMA Guidelines.

Table 1.

Review of literature of aortic dissection and Covid-19 infection.

Country Age Sex Clinical manifestation Comorbidities COVID-19 Timing of dissection Dissection Diagnostic method Dissection type (Stanford/DeBakey) Extension of dissection Surgical treatment
Basheer et al.20 USA 17 M Acute-onset substernal chest pain; COVID-19;
Marfan-syndrome
Tested positive (test not specified) 14 days after covid test + CTA Stanford Type A;
DeBakey type I
From sinotubular junction to proximal aortic arch Single side branch graft (Gelweave-30 mm)
Engin et al.21 Turkey 62 M Chest pain radiating to back;
COVID-19;
AF; DM; lower extremity deep venous insufficiency
Tested positive (test not specified) 20 days after covid symptoms CT Stanford type A;
DeBakey type I
from
ascending aorta to iliac bifurcation
Aortotomy;
poly-tetrafluoroethylene tube graft replacement (30 mm)
Fesharaki et al.22 Iran 43 M Severe chest discomfort COVID-19 RT-PCR Test Positive 21 days after covid symptoms and covid test + CTA Stanford type A;
DeBakey type I
from right Valsalva sinus to ascending aorta, aortic arch, descending thoracic aorta, and renal arteries
Bental surgery with the repair of the right coronary artery
Fukuhara et al.23 USA 52 M Chest pain; abdominal pain; low-grade fever COVID-19 RT-PCR Test Positive Same day as covid symptoms CTA Stanford type A;
DeBakey type I
From sinotubular junction to the superior mesenteric and bilateral
renal arteries
ascending and hemiarch aortic replacement
Jariwala et al.24 India 45 M fever; cough and dyspnea COVID-19 RT-PCR Test Positive 3 days after covid test+ CT Stanford Type B;
DeBakey type III
from below the origin of the left subclavian artery to origin of celiac trunk Endo-vascular Aortic Repair (EVAR)
Martens et al.25 Belgium 64 M acute onset
chest pain; ischemia of the right leg.
COVID-19 RT-PCR Test Positive Same day as covid symptoms CT Stanford type A;
DeBakey type I
from sinotubular junction to iliac arteries Surgical aortic substitution
Mori et al.26 USA 82 F Sudden onset chest pain; facial weakness; anuria; acute kidney injury COVID-19; paroxysmal atrial fibrillation; diastolic heart failure; COPD; pace maker for sick sinus syndrome; aortic valve insufficiency Clinically suspected
Same day as covid symptoms TEE Stanford type A;
DeBakey type II
From ascending aorta to right, noncoronary, and left coronary sinuses Aortic valve resuspension; coronary sinus reconstruction; ascending aorta and hemiarch replacement with Dacron Geaweave graft
Tabaghi et al.27 Iran 47 F Dyspnea; dry cough; bloody diarrhea; chills COVID-19;
Severe; aortic valve insufficiency (post-COVID)
RT-PCR Test Positive 22 days after covid test+ TTE Stanford type A;
DeBakey type II
Ascending aorta Non (the patient expired without intervention)
Volvovitch et al.28 Israel 73 F Chest pain COVID-19;
Hyperlipidemia; impaired fasting glucose
RT-PCR Test Positive Same day as covid test + CTA Stanford type A;
DeBakey type I
From proximal side of
brachiocephalic artery to aortic arch
bilateral pulmonary embolectomy; ascending aorta and hemiarch replacement with a Dacron Tube Graft 28 mm
Zheng et al.29 China 40 F
fever; coughing; expectoration; edema of the limbs COVID-19;
HTN;
CKD; uremia;
Hemodialysis; pulmonary embolism (post-COVID)
RT-PCR Test Positive 21 days after covid test+ CT, CTA Stanford type A;
DeBakey type I
from ascending aorta to left internal iliac
artery and external iliac artery
Bentall's procedure;
total arch replacement; “frozen” elephant trunk stent placemen
Akgul et al.30 Turkey 68 F pulseless R. femoral artery; pulmonary rales at base of both lungs; hypertension (165/90) COVID-19 Tested positive on admission (test not specified) NR CT Stanford Type A;
DeBakey type I
From ascending aorta extending through the right common iliac artery Aortic
transection
above commissures
+ Dacron graft (28 mm)
Farkash et al.31 USA 53 M NR COVID-19; Obesity; Hyperlipidemia RT-PCR Test Positive Same day as covid test + Angiography Stanford type A;
DeBakey type I
From sinotubular junction to the iliac bifurcation ascending and hemiarch aortic replacement
Mamishi et al.32 Iran 14 M High grade fever; weakness; myalgia; dry cough COVID-19;
William's syndrome
RT-PCR Test Positive 25 days after covid test+ Autopsy Stanford type A NR Non (the patient expired without intervention)
Naderi et al.33 Iran 22 M Compressive chest pain with radiation to back; dyspnea; sore throat; cough COVID-19 Imaging and clinically suspected NR CTA Stanford type A;
DeBakey type I
from sinotubular junction
to aortic arch, descending aorta and abdominal
aorta
Patient was transferred to COVID hospital
Firstenberg et al.34 USA 77 M Loss of consciousness COVID-19;
HTN
RT-PCR Test Positive Same day as covid test + TEE Stanford type A NR NR
Katsiampoura et al.35 USA 46 M Acute chest pain radiating to back and L. lower extremity COVID-19 RT-PCR Test Positive NR CT Stanford type A
NR ascending aorta repair with tube graft
Lopez-Marco et al.36 UK 55 M NR COVID-19 Imaging and clinically suspected NR CT Stanford type A;
DeBakey type I
Aortic Root, ascending aorta and aortic arch NR
Lopez-Marco et al.36 UK 53 F NR COVID-19 RT-PCR Test Positive NR CT Stanford type A;
DeBakey type I
Ascending aorta and hemiarch NR
He et al.37 China
51 M sudden on-set chest pain; low-grade fever; hypertension (205/112) COVID-19;
HTN
Clinically suspected
NR NR Stanford type A
NR Surgical aortic substitution
He et al.37 China
51 M sudden on-set chest pain; hypertension (171/73) COVID-19;
HTN
Clinically suspected
NR NR Stanford type A
NR Surgical aortic substitution
He et al.37 China
62 M sudden on-set chest pain; hypertension (149/60) COVID-19; Clinically suspected
NR NR Stanford type A NR Surgical aortic substitution
He et al.37 China
59 F sudden on-set chest pain; fever; hypertension (159/76) COVID-19;
HTN
Clinically suspected
NR NR Stanford type A
NR Surgical aortic substitution
Roman et al.38 UK 74 F NR COVID-19;
Ex-smoker;
HTN
Imaging and clinically suspected NR NR Stanford type A;
DeBakey type I
NR no operation was done due to covid pandemics

The overall quality of cases was good to moderate. Most cases have adequately mentioned demographic data, chief complaint, past medical history, history of Covid-19 detection, type of the aortic dissection, and the surgical method of choice (82.60%). Only 13 (56.52%) cases had the time interval between aortic dissection and the Covid-19 infection reported.

Total of 23 patients were included in this study; Of which 15 (65.22%) were men. The mean age of the patients was 52.61 years (Range:14-82; ± 17.84 SD). The majority of cases were reported from United States of America (n=6; 26.09%), China (n=5; 21.74%), and Iran (n=4; 17.40%). The most common clinical presentation was chest pain (68.42%), followed by cough and hypertension, both of which were seen in 26.32% of patients. The most prevalent Comorbidities found was a history of hypertension (26.09%).

The patients were proven to be infected by Covid-19 via either Reverse transcription polymerase chain reaction (RT-PCR) (n=12; 52.17%), pulmonary imaging (n=3; 13.04%), or on clinical basis (n=8; 34.78%). The mean time interval between occurrence of Covid-19 and the dissection was 9.69 days (Range: 0-25; ± 10.70 SD).10 patients (43.47%) did not have the time of Covid-19 diagnosis in their records.

The main diagnostic technique for aortic dissection was Computed tomography (CT; 44.44%), followed by CT-angiography (CTA; 33.33%) and Transesophageal Echocardiography (TEE; 11.11%). The least frequent method of use was transthoracic echocardiography (TTE; 5.56%). The diagnostic method was not mentioned for 5 patients (21.74%). Considering the type of aortic dissection, 22 patient (95.65%) had Stanford type A aortic dissection, while 1 (4.35%) patient had Stanford type B. If categorized based on DeBakey classification, 20 patients (86.96%) were diagnosed with DeBakey type I, followed by 2 (8.70%) and 1 (4.35%) patient diagnosed by type II and III, respectively.

Discussion

Aortic dissection is a form of acute aortic syndrome that is more prevalent in men (2:1) and has a peak incidence in the sixth and seventh decades of life. It is known that the incidence of aortic dissection increases in cold seasons and places with lower climate temperature. Notably, in one study held in the United Kingdom in April 2020, the number of patients with Stanford type A acute aortic dissection was significantly higher than the same month in the last decade.5 Although no signs of aortitis were found in evaluation of these patients, there should be a mutual factor between these patients that has increased this relatively rare manifestation. Similar studies have also demonstrated increase in the incidence of aortic dissection, along with other cardiovascular manifestations such as myocardial infarction and aortic aneurysms in the first wave of Covid-19.39

Among the risk factors, hypertension is one of the most prevalent causes of increased risk of aortic dissection. Some studies suggested that Covid-19 infection down-regulates angiotensin-converting enzyme 2 and activates renin–angiotensin–aldosterone system, causing the hypertensive state which may lead further towards aortic dissection.40 these findings, along with other molecular findings discussed earlier, intensify the role of Covid-19 in predisposing patients to aortic dissection.

For diagnostic aspects of aortic dissection, several imaging modalities have been proposed; including plain chest radiography, CT, CTA, TEE, and TTE.7 While TEE has overcome many of the constraints in other methods, the majority of patients in this study were diagnosed using CT. This may probably due to non-invasiveness and speed of CT while reducing the Covid-19 exposure for the medical staff compared to the TEE procedure. It is worthy to mention that high level protection is suggested for surgical procedures in patients with Covid-19, which further complicate any method of diagnosis other than noninvasive methods.29

In conclusion, aortic dissection may be a relatively rare but important complication in Covid-19 patients. Henceforth further research and investigation is necessary for diagnosis, prevention, and treatment of this major problem.

References

  • 1.Lotfi M, Rezaei N. SARS-CoV-2: A comprehensive review from pathogenicity of the virus to clinical consequences. Journal of medical virology. 2020;92(10):1864–1874. doi: 10.1002/jmv.26123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Natarelli L, Virgili F, Weber C. SARS-CoV-2, Cardiovascular Diseases, and Noncoding RNAs: A Connected Triad. International Journal of Molecular Sciences. 2021;22(22):12243. doi: 10.3390/ijms222212243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Hernugrahanto KD, Utomo DN, Hariman H, Budhiparama N, Hertanto DM, Santoso D, et al. Thromboembolic involvement and its possible pathogenesis in COVID-19 mortality: lesson from post-mortem reports. European Review for Medical and Pharmacological Sciences. 2021;25:1670–1679. doi: 10.26355/eurrev_202102_24878. [DOI] [PubMed] [Google Scholar]
  • 4.Mazaherpour H, Soofian M, Farahani E, Masfari Farahani F, Ghaznavi Rad E, Mazaherpour S, et al. Frequency of Cardiovascular Complications and Its Association with Prognosis of COVID-19 Patients. BioMed Research International. 2021;2021 doi: 10.1155/2021/7073348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Ali J, Vokshi I, Ng C, Falter F, De Silva R. The COVID-19 Pandemic and Acute Aortic Dissection: an unintended consequence? Authorea Preprints. 2020 [Google Scholar]
  • 6.Klein DG. Thoracic aortic aneurysms. Journal of Cardiovascular Nursing. 2005;20(4):245–250. doi: 10.1097/00005082-200507000-00008. [DOI] [PubMed] [Google Scholar]
  • 7.Kamalakannan D, Rosman HS, Eagle KA. Acute aortic dissection. Critical care clinics. 2007;23(4):779–800. doi: 10.1016/j.ccc.2007.07.002. [DOI] [PubMed] [Google Scholar]
  • 8.Wang D, Li R, Wang J, Jiang Q, Gao C, Yang J, et al. Correlation analysis between disease severity and clinical and biochemical characteristics of 143 cases of COVID-19 in Wuhan, China: a descriptive study. BMC infectious diseases. 2020;20(1):1–9. doi: 10.1186/s12879-020-05242-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Goudarzi E, Yousefimoghaddam F, Ramandi A, Khaheshi I. COVID-19 and peripheral artery thrombosis: A mini review. Current Problems in Cardiology. 2021 doi: 10.1016/j.cpcardiol.2021.100992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Yin J, Wang S, Liu Y, Chen J, Li D, Xu T. Coronary microvascular dysfunction pathophysiology in COVID-19. Microcirculation. 2021:e12718. doi: 10.1111/micc.12718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Ghazavi A, Ganji A, Keshavarzian N, Rabiemajd S, Mosayebi G. Cytokine profile and disease severity in patients with COVID-19. Cytokine. 2021;137 doi: 10.1016/j.cyto.2020.155323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Iskandar Z, Mordi I, Lang CC, Huang JT, Choy A-M. Biomarkers of aortopathy in Marfan syndrome. Cardiology in review. 2020;28(2):92–97. doi: 10.1097/CRD.0000000000000289. [DOI] [PubMed] [Google Scholar]
  • 13.Ponti G, Maccaferri M, Ruini C, Tomasi A, Ozben T. Biomarkers associated with COVID-19 disease progression. Critical reviews in clinical laboratory sciences. 2020;57(6):389–399. doi: 10.1080/10408363.2020.1770685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Giusti B, Porciani MC, Brunelli T, Evangelisti L, Fedi S, Gensini GF, et al. Phenotypic variability of cardiovascular manifestations in Marfan Syndrome: Possible role of hyperhomocysteinemia and C677T MTHFR gene polymorphism. European heart journal. 2003;24(22):2038–2045. doi: 10.1016/j.ehj.2003.08.020. [DOI] [PubMed] [Google Scholar]
  • 15.Shi S, Su M, Shen G, Hu Y, Yi F, Zeng Z, et al. Matrix metalloproteinase 3 as a valuable marker for patients with COVID-19. Journal of medical virology. 2021;93(1):528–532. doi: 10.1002/jmv.26235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Petito E, Falcinelli E, Paliani U, Cesari E, Vaudo G, Sebastiano M, et al. Neutrophil more than platelet activation associates with thrombotic complications in COVID-19 patients. The Journal of Infectious Diseases. 2020 doi: 10.1093/infdis/jiaa756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Abers MS, Delmonte OM, Ricotta EE, Fintzi J, Fink DL, de Jesus AAA, et al. An immune-based biomarker signature is associated with mortality in COVID-19 patients. JCI insight. 2021;6(1) doi: 10.1172/jci.insight.144455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Ma L-L, Wang Y-Y, Yang Z-H, Huang D, Weng H, Zeng X-T. Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better? Military Medical Research. 2020;7(1):1–11. doi: 10.1186/s40779-020-00238-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Moola S, M Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, Currie M, Qureshi R, Mattis P, Lisy K, Mu P-F. In: Joanna Briggs Institute Reviewer's Manual. Aromataris E, Munn Z, editors. The Joanna Briggs Institute; 2017. Chapter 7: Systematic reviews of etiology and risk.https://reviewersmanual.joannabriggs.org/ Available from. [Google Scholar]
  • 20.Basheer A, Rasool M, Amin H, Saucier S, editors. Baylor University Medical Center Proceedings. Taylor & Francis; 2021. Acute aortic dissection in the Marfan syndrome during the COVID-19 epidemic. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Engin M, Aydın U, Eskici H, Ata Y, Türk T. Type 1 Acute Aortic Dissection in the Early Period After COVID-19 Infection. Cureus. 2021;13(3):e13751. doi: 10.7759/cureus.13751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Fesharaki MJ, Ansariaval Z, Alizadehasl A. Successful surgery in acute type a dissection in a patient with covid-19. Iranian Heart Journal. 2020;21(4):135–139. [Google Scholar]
  • 23.Fukuhara S, Rosati CM, El-Dalati S. Acute Type A Aortic Dissection During the COVID-19 Outbreak. Ann Thorac Surg. 2020;110(5):e405–e4e7. doi: 10.1016/j.athoracsur.2020.04.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Jariwala P, Kamble R, Kale SS, Mishra KC, Jadhav KP. A fatal association of COVID-19 and acute complicated Type-B aortic dissection: Interventional management in a difficult situation. IHJ Cardiovascular Case Reports (CVCR) 2021;5(2):94–97. [Google Scholar]
  • 25.Martens T, Vande Weygaerde Y, Vermassen J, Malfait T. Acute Type A Aortic Dissection Complicated by COVID-19 Infection. Ann Thorac Surg. 2020;110(5):e421–e4e3. doi: 10.1016/j.athoracsur.2020.05.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Mori M, Geirsson A, Vallabhajosyula P, Assi R. Surgical management of thoracic aortic emergency with pre- and postoperative COVID-19 disease. J Card Surg. 2020;35(10):2832–2834. doi: 10.1111/jocs.14865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Tabaghi S, Akbarzadeh MA. Acute type A aortic dissection in a patient with COVID-19. Future cardiology. 2020;17(4):625–629. doi: 10.2217/fca-2020-0103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Volvovitch D, Ram E, Cohen H, Kogan A, Sternik L, Raanani E. Acute pulmonary embolism following acute type A aortic dissection in a patient with COVID-19. J Card Surg. 2021;36(4):1566–1568. doi: 10.1111/jocs.15389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Zheng H, Deng Q, Chi X, Chen M, Xu L, Peng YG, et al. Successful Anesthesia Management in a Patient With Type A Aortic Dissection Complicated by Renal Failure and Suspected Coronavirus Disease. Semin Cardiothorac Vasc Anesth. 2021;25(1):39–45. doi: 10.1177/1089253220969052. [DOI] [PubMed] [Google Scholar]
  • 30.Akgul A, Turkyilmaz S, Turkyilmaz G, Toz H. Acute Aortic Dissection Surgery in a Patient With COVID-19. Annals of Thoracic Surgery. 2021;111(1):e1–e3. doi: 10.1016/j.athoracsur.2020.06.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Farkash EA, Wilson AM, Jentzen JM. Ultrastructural Evidence for Direct Renal Infection with SARS-CoV-2. J Am Soc Nephrol. 2020;31(8):1683–1687. doi: 10.1681/ASN.2020040432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Mamishi S, Navaeian A, Shabanian R. Acute aortic dissection in a patient with Williams syndrome infected by COVID-19. Cardiology in the Young. 2020 doi: 10.1017/S1047951120003236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Naderi N, Ansari Ramandi MM, Baay M, Hosseini Z, Zanganehfar ME, Rabieie P, et al. Cardiovascular patients in COVID-19 era, a case series, an experience from a tertiary cardiovascular center in Tehran, Iran. Clin Case Rep. 2020;8(12):2436–2442. doi: 10.1002/ccr3.3163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Firstenberg MS, Libby M, Ochs M, Hanna J, Mangino JE, Forrester J. Isolation protocol for a COVID-2019 patient requiring emergent surgical intervention: Case presentation. Patient Safety in Surgery. 2020;14(1) doi: 10.1186/s13037-020-00243-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Katsiampoura A, Perozo C, Varkaris A, Vellayappan S, Tam MZ, Vellayappan U, et al. Covid-19 positivity affects outcome of cardiac surgical patients. Journal of Cardiac Surgery. 2020;35(12):3650–3652. doi: 10.1111/jocs.14982. [DOI] [PubMed] [Google Scholar]
  • 36.Lopez-Marco A, Harky A, Malvindi PG, Verdichizzo D, McPherson I, Roman M, et al. Type A aortic syndromes in COVID-19 positive patients: Case series from a UK multicentre study. J Card Surg. 2021;36(8):2692–2696. doi: 10.1111/jocs.15625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.He H, Zhao S, Han L, Wang Q, Xia H, Huang X, et al. Anesthetic Management of Patients Undergoing Aortic Dissection Repair With Suspected Severe Acute Respiratory Syndrome COVID-19 Infection. J Cardiothorac Vasc Anesth. 2020;34(6):1402–1405. doi: 10.1053/j.jvca.2020.03.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Roman M, Harky A, Brazier A, Lim K, Gradinariu G, Oo A, et al. Turn down of acute aortic syndrome cases during COVID-19: Results from UK multicentre studies. Journal of Cardiac Surgery. 2021;36(1):199–202. doi: 10.1111/jocs.15187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Bollmann A, Hohenstein S, Pellissier V, König S, Ueberham L, Hindricks G, et al. Hospitalizations for emergency-sensitive conditions in Germany during the Covid-19 pandemic-Insights from the German-wide Helios hospital network. medRxiv. 2021 doi: 10.1136/emermed-2021-211183. [DOI] [PubMed] [Google Scholar]
  • 40.Bissacco D, Franchin M, Piffaretti G, Luzzani L, D'oria M, Casana R, editors. Seminars in Vascular Surgery. Elsevier; 2021. Impact of COVID-19 on aortic operations. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Current Problems in Cardiology are provided here courtesy of Elsevier

RESOURCES